These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3118438)

  • 1. The direct mutagenicity of aflatoxin B1 and metabolites to Salmonella typhimurium: structure mutagenicity relationships and mechanisms of action.
    Yourtee DM; Kirk-Yourtee CL; Searles S
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):55-76. PubMed ID: 3118438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical effect in the mutagenicity of the aflatoxicols toward Salmonella typhimurium.
    Yourtee DM; Kirk-Yourtee CL; Searles S
    Life Sci; 1987 Oct; 41(15):1795-803. PubMed ID: 3309517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the mutagenic effect of a medium containing aflatoxin B1 as a result of the yeast activity].
    Borisenko AE; Mirskaia EE; Borisenko EG
    Gig Sanit; 1990 Dec; (12):45-7. PubMed ID: 2128746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative aflatoxin B1 mutagenesis of Salmonella typhimurium TA 100 in metabolic and photoactivation systems.
    Israel-Kalinsky H; Malca-Mor L; Stark AA
    Cancer Res; 1984 May; 44(5):1831-9. PubMed ID: 6424931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by specific antibodies of the mutagenicity of aflatoxin B1 in bacteria.
    Sizaret P; Malaveille C; Brun G; Aguelon AM; Toussaint G
    Oncodev Biol Med; 1982; 3(2-3):125-34. PubMed ID: 6812028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of tetramic mycotoxin cyclopiazonic acid.
    Sorenson WG; Tucker JD; Simpson JP
    Appl Environ Microbiol; 1984 Jun; 47(6):1355-7. PubMed ID: 6430233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of butylated hydroxytoluene on the in vitro metabolism, DNA-binding and mutagenicity of aflatoxin B1 in the rat.
    Fukayama MY; Hsieh DP
    Food Chem Toxicol; 1984 May; 22(5):355-60. PubMed ID: 6427081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of mutagenic and antimutagenic activities of alpha-bisabolol in the Salmonella/microsome assay.
    Gomes-Carneiro MR; Dias DM; De-Oliveira AC; Paumgartten FJ
    Mutat Res; 2005 Aug; 585(1-2):105-12. PubMed ID: 15936245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
    Jayaraj A; Hardwick JP; Diller TW; Richardson AG
    J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
    Uwaifo AO; Bababunmi EA
    Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promutagen activation in partially hepatectomized mice.
    Vandewaa EA; Barney CC; Gentile JM
    Toxicol Lett; 1982 Dec; 14(3-4):253-60. PubMed ID: 6820200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain differences in the metabolic activation of aflatoxin B1 in the rat.
    Plummer S; Boobis AR; Davies DS
    Xenobiotica; 1987 Feb; 17(2):199-208. PubMed ID: 3105188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of propolis and bee venom on the mutagenicity of some direct- and indirect-acting mutagens.
    Varanda EA; Monti R; Tavares DC
    Teratog Carcinog Mutagen; 1999; 19(6):403-13. PubMed ID: 10587410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses.
    Baertschi SW; Raney KD; Shimada T; Harris TM; Guengerich FP
    Chem Res Toxicol; 1989; 2(2):114-2. PubMed ID: 2519710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the mutagenicity and antimutagenicity of beta-ionone in the Salmonella/microsome assay.
    Gomes-Carneiro MR; Dias DM; Paumgartten FJ
    Food Chem Toxicol; 2006 Apr; 44(4):522-7. PubMed ID: 16223554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of mutagenic activity of aflatoxins after UV-irradiation.
    Kleinwächter V; Koukalová B
    Acta Biol Med Ger; 1979; 38(9):1239-42. PubMed ID: 399142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential.
    Wong JJ; Hsieh DP
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2241-4. PubMed ID: 781672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.